primary peritoneal carcinoma
Showing 76 - 100 of 105
Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in El Palmar.
Unknown status
- Peritoneal Carcinomatosis From Ovarian Cancer
- +2 more
- Cytoreduction
- Hipec with Cisplatin
-
El Palmar., Murcia, SpainHospital Clínico Universitario Virgen de la Arrixaca
Dec 12, 2017
Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Minneapolis (Fludarabine, Cyclophosphamide, NK
Completed
- Ovarian Cancer
- +2 more
- Fludarabine
- +4 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Dec 3, 2017
Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in
Terminated
- Malignant Ovarian Mixed Epithelial Tumor
- +7 more
- Carboplatin
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Aug 8, 2017
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (drug, procedure,
Withdrawn
- Fallopian Tube Carcinoma
- +4 more
- Cyclophosphamide
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 12, 2017
Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (Paclitaxel Poliglumex)
Completed
- Primary Peritoneal Carcinoma
- Recurrent Ovarian Carcinoma
- Paclitaxel Poliglumex
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 12, 2017
Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Phoenix (Cositecan, Pharmacological Study)
Completed
- Primary Peritoneal Carcinoma
- Recurrent Ovarian Carcinoma
- Cositecan
- Pharmacological Study
-
Phoenix, ArizonaGynecologic Oncology Group of Arizona
Jul 12, 2017
Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma, Ovarian Carcinosarcoma Trial in Oklahoma City (Avastin, Paclitaxel,
Completed
- Advanced Ovarian Carcinoma
- +2 more
- Avastin
- +2 more
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Jun 2, 2017
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Boston (Tivozanib)
Terminated
- Ovarian Cancer
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
May 4, 2017
Breast Cancer, Cervical Cancer, Endometrial Cancer Trial in Los Angeles, New York (compound 31543 Calcitriol)
Completed
- Breast Cancer
- +7 more
- compound 31543 Calcitriol
-
Los Angeles, California
- +1 more
Apr 21, 2017
Ovarian Carcinoma, Stage 3 or 4, Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Portland (Paclitaxel,
Withdrawn
- Ovarian Carcinoma, Stage 3 or 4
- +2 more
- Paclitaxel
- +2 more
-
Portland, OregonOregon Health & Science University
Apr 19, 2017
Invasive Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in St Louis (Propranolol)
Completed
- Invasive Epithelial Ovarian Cancer
- +2 more
-
St Louis, MissouriWashington University in St. Louis
Jan 11, 2017
Bulky Stage IIIC and IV Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in China (PEip
Completed
- Bulky Stage IIIC and IV Epithelial Ovarian Cancer
- +2 more
- PEip (weekly) and TCiv
- TCiv
-
Nanjing, Jiangsu, China
- +6 more
Dec 15, 2016
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Pittsburgh (RAD001, bevacizumab)
Completed
- Ovarian Cancer
- +2 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital of UPMC
Jul 19, 2016
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Total or Subtotal Colectomy,
Unknown status
- Epithelial Ovarian Cancer
- +3 more
- Total or Subtotal Colectomy
- Other Bowel Resection
-
Shanghai, Shanghai, ChinaFudan University Shanghai Zhongshan Hospital
Jul 23, 2016
Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Brussels, Liège (HIPEC)
Completed
- Ovarian Carcinoma
- +2 more
- HIPEC
-
Brussels, Belgium
- +1 more
Feb 23, 2016
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (3-Dimensional
Completed
- Fallopian Tube Carcinoma
- +4 more
- 3-Dimensional Conformal Radiation Therapy
- +2 more
-
Chicago, Illinois
- +6 more
Feb 10, 2016
Ovarian Adenocarcinoma, Fallopian Tube Adenocarcinoma, Primary Peritoneal Carcinoma Trial in Villejuif (Cisplatin, Bevacizumab)
Completed
- Ovarian Adenocarcinoma
- +2 more
-
Villejuif, Val de Marne, FranceGustave Roussy
Jan 25, 2016
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in New York (Irinotecan, Bevacizumab)
Completed
- Ovarian Cancer
- +2 more
-
New York, New York
- +1 more
Oct 26, 2015
Women at Elevated Genetic Risk for Ovarian Cancer Who
Not yet recruiting
- Fallopian Tube Carcinoma
- +3 more
- Evaluation of Cancer Risk Factors
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma, Stage IV Ovarian Cancer Trial in Duarte (biological, drug, other)
Completed
- Primary Peritoneal Carcinoma
- +2 more
- Bevacizumab
- +2 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
May 8, 2015
Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor Trial in Philadelphia (Carboplatin,
Completed
- Fallopian Tube Carcinoma
- +10 more
- Carboplatin
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 7, 2015
Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Seongnam-si (weekly paclitaxel,
Unknown status
- Epithelial Ovarian Carcinoma
- +2 more
- weekly paclitaxel
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Jan 22, 2015
Fallopian Tube Carcinoma, Infectious Disorder, Neutropenia Trial in United States (procedure, drug, biological)
Completed
- Fallopian Tube Carcinoma
- +6 more
- Adjuvant Therapy
- +3 more
-
Orange, California
- +10 more
Dec 29, 2014
Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma, Fallopian Tube Carcinoma Trial in United States (Paclitaxel,
Completed
- Chemotherapeutic Agent Toxicity
- +14 more
-
Chicago, Illinois
- +6 more
Dec 29, 2014
Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in St. Louis (Pemetrexed, Bevacizumab)
Completed
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
-
St. Louis, MissouriWashington University School of Medicine
Oct 10, 2014